Risk-Benefit Analysis

Forever Healthy Foundation gGmbH

Amalienbadstraße 41

D-76227 Karlsruhe, Germany

Senolytics are agents that selectively induce apoptosis of senescent cells. Fisetin is a flavonoid polyphenol found in many types of fruits and vegetables (Arai et al., 2000) that is believed to act as a senolytic in addition to its numerous other known benefits. Although natural senolytics are less potent, compared to the targeted senolytics, they have lower toxicity and are thus, likely to be more readily translatable to clinical medicine. This RBA focuses on the risks and benefits of using fisetin as a senolytic rather than its more common use as a supplement.

Key Questions 

This RBA seeks to answer the following questions:

• Which health and/or longevity benefits result from the use of fisetin as a senolytic? 
• Which risks are involved in the use of fisetin as a senolytic (general and method-specific)?
• What are the potential risk mitigation strategies?
• Which method or combination of methods of using fisetin as a senolytic are most effective?
• Which of the available methods are safe for use?
• What is the best therapeutic protocol available at the moment?  

https://brain.forever-healthy.org/display/EN/Fisetin+Senolytic+Therapy